Entest adds Tammy Reynolds as CFO
This article was originally published in Clinica
Stem cell therapy specialist Entest BioMedical has appointed Tammy Reynolds to the position of CFO. Ms Reynolds joins the firm from Science Applications International Corporation and previously worked as a senior accountant in the areas of financial reporting and tax compliance. La Mesa, California-based Entest specialises in developing stem cell treatments for chronic obstructive pulmonary disease (COPD), immuno-cancer therapies, tests for diabetes and stem cell research applications for diabetes and other illnesses. The firm also developing the ENT-576 laser device for stem cell extraction.
You may also be interested in...
Alere’s professional diagnostics business helped the firm record overall revenue growth in the fourth quarter of 2010, offsetting a fall in influenza-based sales in North America.
Integra LifeSciences has gained exclusive worldwide rights from Stout Medical to develop and commercialise an expandable interbody fusion device.
Gen-Probe recently launched its Panther automated molecular diagnostics system in Europe with the aim of bringing another dimension to its product portfolio. Joseph Harvey met the firm’s CEO, Carl Hull, at the launch of the product in Frankfurt to find how high the firm has set its sights in the molecular diagnostics sector and how it is going to achieve its goals